Metrics as of 10/17/2026, 08:26 AM (Berlin time), refresh in progress.
Sandoz Group AG
Sandoz Group AG is a healthcare company headquartered in Basel. The company specializes in the development, production, and distribution of generic medications and biosimilar products. Its portfolio includes the creation and sale of finished dosage forms for small molecule pharmaceuticals, which are often supplied to…
Company description based on the data provider's company data, AI-assisted, created on 15/10/2026. Not investment advice.
1D
+2.6%
1W
+10.7%
1M
+17.4%
6M
+14.9%
YTD
+33.4%
1Y
+58.5%
2Y
+108.3%
5Y
–
10Y
–
Next earnings date
17/02/2027 (in 123 days)
Volatility around earnings
~148% stronger price swings than usual
Pattern detected by the Market Jury detector vdouble-bottom-top-v1.0 on 15/10/26. Not a buy or sell signal.Beta
What does this mean?
Double bottom
BullishThe price bounced off a similar low twice, with a rally in between. This W-shaped pattern is a classic reversal signal from a downtrend into an uptrend.
Chart patterns are a purely technical signal derived from price action. At Market Jury they do not feed into the agents' buy or sell decisions, they are supplementary information only.
P/E
62.83
P/B
4.51
EV/EBITDA
19.43
RETURN ON EQUITY
1.2%
NET MARGIN
1.9%
DEBT/EQUITY
0.69
DIVIDEND YIELD
1.0%
AS OF
30/06/2026
FREE FLOAT
95.8%
FLOAT SHARES
414,592,803
AVG. DAILY VOLUME (30D)
1,656,221
Sandoz Group AG is a company in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry, headquartered in Switzerland.
The CEO is Richard Saynor, the company employs around 20,000 people.
The IPO was on 03/10/2023; the stock trades on SIX under the ticker SDZ.SW.
The next earnings date is 17/02/2027.
Around past earnings, price swings were roughly 148% stronger than usual.
Yes. The last dividend was CHF 0.80 per share, ex-date 13/04/2026, paid on 15/04/2026.
The dividend yield is 1.0% (as of 30/06/2026).
Comparable stocks include Merck, Takeda Pharmaceutical Company, Teva Pharmaceutical Industries, Zoetis, Viatris, Lantheus Holdings, Amneal Pharmaceuticals and Indivior Pharmaceuticals.
Clicking "Analyze stock" lets five strategies assess Sandoz Group against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.